Thursday, March 20, 2025
HomeIndustriesHealthcare

Healthcare

Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces the first patient dosed in the Phase II clinical trial of...

HotSpot Therapeutics Presents Pre-Clinical Data on CBL-B Program at American Association

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first- and best-in-class small molecule allosteric therapies targeting regulatory sites on proteins...

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...

Joint Statement from CMS Administrator Chiquita Brooks-LaSure and FDA Commissioner Robert M. Califf, M.D., on Ensuring Access to Safe and Effective Treatments

Ensuring the availability of innovative interventions for people is a shared priority for both the Centers for Medicaid & Medicare Services (CMS) and the...

Aidoc Delivers the Most Comprehensive Neuroscience Package for AI-driven Coordination with New FDA 510(k) Clearance for Brain Aneurysm

Aidoc, the leading provider of healthcare AI solutions, announced that it received its 9th FDA 510(k) clearance for triage and notification of brain aneurysm....
0FansLike
0FollowersFollow
spot_img

Hot Topics